Myosin VIIA and Rab Interacting Protein (MYRIP) (Middle Region) Peptide
-
- Target See all MYRIP products
- MYRIP (Myosin VIIA and Rab Interacting Protein (MYRIP))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- WSEALSKLCP RSRALPRNPQ PQPTQAQSSD QGPIAASPSS ALSPNPEAMC
- Characteristics
- This is a synthetic peptide designed for use in combination with anti- MYRIP Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MYRIP (Myosin VIIA and Rab Interacting Protein (MYRIP))
- Synonyms
- SLAC2-C Peptide, SLAC2C Peptide, A230081N12Rik Peptide, Slac2-c Peptide, Slac2c Peptide, MYRIP Peptide, si:dkey-189e1.4 Peptide, LOC100156583 Peptide, myosin VIIA and Rab interacting protein Peptide, MYRIP Peptide, Myrip Peptide, myrip Peptide
- Background
-
Rab effector protein involved in melanosome transport. Serves as link between melanosome-bound RAB27A and the motor proteins MYO5A and MYO7A. May link RAB27A-containing vesicles to actin filaments. Functions as a protein kinase A-anchoring protein (AKAP). May act as a scaffolding protein that links PKA to components of the exocytosis machinery, thus facilitating exocytosis, including insulin release (By similarity).
Alias Symbols: SLAC2C, SLAC2-C
Protein Size: 794 - Gene ID
- 25924
- NCBI Accession
- NM_001284423, NP_001271352
-